Rob Gerberry, Senior Vice President and Chief Legal Officer, Summa Health, speaks with Michael Peregrine about how health care corporate governance may be impacted by the rapid acceleration in artificial intelligence (AI) sophistication and utilization, and the implications for its future development. They discuss how the board should approach its fiduciary responsibilities and interact with senior executive leadership in the face of this rapid AI acceleration.